Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 SEK | 0.00% | 0.00% | -11.31% |
Business Summary
Number of employees: 13
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Nanomedicine
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +59.70% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +59.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mats Hansen
CEO | Chief Executive Officer | 53 | 14-12-31 |
Hanna Olsson
DFI | Director of Finance/CFO | 44 | 19-02-28 |
Oskar Axelsson
CTO | Chief Tech/Sci/R&D Officer | 62 | 06-12-31 |
Paul Hargreaves
PRN | Corporate Officer/Principal | 55 | 21-09-12 |
Tove Sivik Sonne
PRN | Corporate Officer/Principal | 44 | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hans Arwidsson
CHM | Chairman | 66 | 23-05-09 |
Director/Board Member | 64 | 23-05-09 | |
Director/Board Member | 48 | 19-05-07 | |
Kari Grønås
BRD | Director/Board Member | 59 | 17-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 219,507,121 | 170,128,700 ( 77.50 %) | 0 | 77.50 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.31% | 6.1M | |
+82.29% | 4.14B | |
-23.73% | 2.51B | |
-14.73% | 2.34B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+5.02% | 840M | |
-11.75% | 548M | |
-34.49% | 466M | |
+45.95% | 277M |
- Stock
- Equities
- Stock Spago Nanomedical AB - Nasdaq Stockholm
- Company Spago Nanomedical AB